Menstrual Cycle · Cycle Disorders

Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations

Dubey P, Reddy S, Singh V, Yousif A, Dwivedi AK

Published May 23, 2024 BMC medicine, 22(1), 208
DOI 10.1186/s12916-024-03426-8 PMID 38783294 PMC PMC11119710

RRM Academy Synopsis

Heavy periods tied to cardiovascular events in young hospital patients

A study of 2017 US hospital records found that hospitalized women aged 40 or younger with heavy menstrual bleeding had higher odds of cardiovascular events. The link was weaker in women over 40. The design shows association only.

Key Findings

  • In women aged 40 or younger, matched analysis gave odds ratios of 1.61 (95% CI: 1.25, 2.08) for major adverse cardiovascular events and 1.72 (95% CI: 1.10, 2.71) for coronary heart disease.
  • Younger women had odds ratios of 1.95 (95% CI: 1.12, 3.40) for stroke, 1.53 (95% CI: 1.15, 2.03) for heart failure and 1.84 (95% CI: 1.34, 2.54) for atrial fibrillation or arrhythmia.
  • Younger women with heavy bleeding and regular cycles had an odds ratio of 1.69 (95% CI: 1.30, 2.19) for major adverse cardiovascular events.
  • Younger women with heavy bleeding and irregular menstruation had associations only for coronary heart disease (1.95) and atrial fibrillation (1.87).
  • Among women over 40, heavy menstrual bleeding was not robustly associated with cardiovascular events in the primary analysis.

Interpretation

The study is a retrospective cross-sectional analysis of hospital billing codes. It covered 2,430,851 US hospitalizations of women aged 18 to 70. Of those, 18,926 (0.78%) carried a heavy menstrual bleeding diagnosis. The authors state that the design cannot show cause. Without a time gap between the bleeding and the cardiovascular diagnoses, risk could not be estimated. Every woman was hospitalized, so the results describe hospitalized women. The codes may undercount heavy bleeding. The data lacked bleeding onset, family history and diet.

RRM Context

Restorative reproductive medicine treats a heavy period as a signal to look for the underlying cause. The authors note that heavy bleeding often comes from uterine, hormonal or clotting conditions. Suppressive medications, which the paper lists among treatments, quiet the bleeding. They do not identify the condition behind it.

Abstract

Background

Heavy menstrual bleeding (HMB) is a common menstrual disorder associated with multiple risk factors of cardiovascular disease (CVD) in women. In addition, HMB is often present with irregular menstruation (IM) which is a risk factor for CVD outcomes. However, the relationship between HMB and CVD outcomes is unexplored in the presence or absence of IM. We determined the association of HMB with multiple CVD outcomes using a nationally representative sample of female hospitalizations in the US.

Methods

All hospitalizations of females with HMB diagnosis and normal menstrual cycles from ages of 18 to 70 years were extracted from the National Inpatient Sample Database, 2017. The HMB was defined using the International Classification of Diseases (ICD)-10 for excessive and frequent menstruation bleeding and included any current or history of HMB diagnosis. Outcomes including major adverse cardiovascular events (MACE), coronary heart disease (CHD), stroke, heart failure (HF), atrial fibrillation (AF) or arrhythmia, myocardial infarction (MI), and diabetes (DM) were defined using ICD-10 codes. Adjusted logistic regression and prosperity scores-matched logistic regression analyses were conducted to summarize adjusted associations with an odds ratio (OR) and a 95% confidence interval (CI).

Results

Among 2,430,851 hospitalizations, HMB was observed in 7762 (0.68%) females with age ≤ 40 years and 11,164 (0.86%) females with age > 40 years. Among hospitalizations with age ≤ 40 years, HMB was significantly associated with increased odds of CVD outcomes including MACE (OR = 1.61; 95% CI: 1.25, 2.08), CHD (OR = 1.72; 95% CI: 1.10, 2.71), stroke (OR = 1.95; 95% CI: 1.12, 3.40), HF (OR = 1.53; 95% CI: 1.15, 2.03), and AF/arrhythmia (OR = 1.84; 95% CI: 1.34, 2.54). These associations were confirmed in multiple sensitivity analyses. In contrast, HMB was not robustly associated with CVD events among hospitalizations of women with age > 40 years. HMB without IM was strongly associated with DM, HF, AF, and MACE outcomes while HMB with IM was strongly associated with CHD and AF outcomes in hospitalizations of young women.

Conclusions

HMB is associated with CVD events among US hospitalizations of young women. A routine investigation and screening of menstrual disorders, especially HMB, is useful for CVD risk stratification and management in young women.

Topics

By this author

Related research

Menstrual Cycle › Cycle Disorders › Abnormal Uterine Bleeding
Pallavi Dubey, Sireesha Reddy, Vishwajeet Singh, Abdelrehman Yousif, Alok Kumar Dwivedi
P Dubey, S Reddy, V Singh, A Yousif, A Dwivedi
PMID 38783294 38783294 DOI 10.1186/s12916-024-03426-8 10.1186/s12916-024-03426-8 Dubey et al. 2024, Dubey 2024